Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

59
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
59
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.9K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-performance proteomics reveals immune, epithelial, and vascular dysregulation underlying lacrimal fluid defects in patients with aniridia.

BMC ophthalmology·2026
Same author

Evaluation of the contribution of trio-exome sequencing in selected prenatal indications.

Frontiers in genetics·2026
Same author

A dataset of patients with isolated and syndromic optic neuropathies linked to RTN4IP1 genetic variants.

Scientific data·2026
Same author

Correction: Comprehensive analysis of CNOT3-related neurodevelopmental disorders: phenotypic and genotypic characterization.

European journal of human genetics : EJHG·2026
Same author

Expanding the Phenotypic Spectrum Associated With Loss-of-Function SMARCA4 Variants to Eye Developmental Anomalies.

Clinical genetics·2026
Same author

Insights Into the FOXE3 Transcriptional Network and Disease Mechanisms From the Investigation of a Regulatory Variant Driving Complex Microphthalmia.

Investigative ophthalmology & visual science·2025

Related Experiment Video

Updated: Mar 11, 2026

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
07:04

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System

Published on: February 4, 2021

2.5K

Genetic Advances in Microphthalmia.

Julie Plaisancie1, Patrick Calvas2, Nicolas Chassaing2

  • 1Department of Medical Genetics, Purpan University Hospital, Toulouse, France.

Journal of Pediatric Genetics
|November 30, 2016
PubMed
Summary

Genetic testing now identifies the cause of anophthalmia and microphthalmia (AM) in over 50% of severe cases. Advances in molecular screening improve diagnosis and genetic counseling for AM patients.

Keywords:
anophthalmiaeye developmentgenetic advancesmicrophthalmia

More Related Videos

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

22.3K
Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye
05:09

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye

Published on: November 25, 2012

34.4K

Related Experiment Videos

Last Updated: Mar 11, 2026

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
07:04

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System

Published on: February 4, 2021

2.5K
Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
06:48

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium

Published on: August 7, 2015

22.3K
Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye
05:09

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye

Published on: November 25, 2012

34.4K

Area of Science:

  • Ophthalmology
  • Genetics
  • Developmental Biology

Background:

  • Anophthalmia and microphthalmia (AM) are severe congenital ocular anomalies impacting craniofacial development.
  • Genetic factors are the predominant cause of these ocular globe malformations.
  • Historically, genetic diagnostic capabilities for AM were limited, restricting routine testing to a few genes.

Approach:

  • Recent advancements in molecular screening technologies have significantly enhanced the understanding of AM's genetic basis.
  • These technologies allow for broader genetic analysis in affected individuals.
  • The study highlights the improved diagnostic yield due to these new methods.

Key Points:

  • Genetic causes are now identifiable in over 50% of patients with severe bilateral eye phenotypes and approximately 30% of all AM patients.
  • Improved genetic identification aids in understanding the molecular underpinnings of AM.
  • Knowledge of genetic bases is crucial for accurate diagnosis and prognosis.

Conclusions:

  • The increased identification of genetic causes in AM patients represents a significant leap in diagnostic capability.
  • Enhanced genetic knowledge improves the quality of care, including diagnosis, prognosis, and genetic counseling.
  • Continued research into the genetic etiology of AM is vital for advancing patient management and family support.